Evidence map›Paper›PMID 41934182›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Proximity-Induced Transfer of a Mass Tag Enables Direct Profiling of Active Matrix Metalloproteases.

Lomane Berthy, Ugo Pasco, Mylene Sejalon-Cipolla, Pierrick Bruyat, Monika Kaminska, Carole Malgorn, Fabrice Beau, Manca Osolin, Metka Novak, Barbara Breznik and 11 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Lomane BerthyCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.
Ugo PascoIBMM, Univ. Montpellier, ENSCM, CNRS, Montpellier, France.
Mylene Sejalon-CipollaIBMM, Univ. Montpellier, ENSCM, CNRS, Montpellier, France.
Pierrick BruyatCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.
Monika KaminskaCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.
Carole MalgornCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.
Fabrice BeauCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.
Manca OsolinNational Institute of Biology, Department of Genetic Toxicology and Cancer Biology, 121 Večna pot, Ljubljana, Slovenia.
Metka NovakNational Institute of Biology, Department of Genetic Toxicology and Cancer Biology, 121 Večna pot, Ljubljana, Slovenia.
Barbara BreznikNational Institute of Biology, Department of Genetic Toxicology and Cancer Biology, 121 Večna pot, Ljubljana, Slovenia.
Dimitris GeorgiadisDepartment of Chemistry, Laboratory of Organic Chemistry, University of Athens, Panepistimiopolis, Zografou, Athens, Greece.
Isabelle CorreiaSorbonne Université, Ecole Normale Supérieure, PSL University, CNRS, Chimie Physique, et Chimie du Vivant, CPCV, Paris, France.
Emeline GroultIRMB, University of Montpellier, INSERM, CHU, Montpellier, France.
Olivier LequinSorbonne Université, Ecole Normale Supérieure, PSL University, CNRS, Chimie Physique, et Chimie du Vivant, CPCV, Paris, France.
Sarah BregantCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.
Yves-Marie PersIRMB, University of Montpellier, INSERM, CHU, Montpellier, France.
Daniele NoelIRMB, University of Montpellier, INSERM, CHU, Montpellier, France.
Robert ThaiCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.
Gilles SubraIBMM, Univ. Montpellier, ENSCM, CNRS, Montpellier, France.
Sonia CantelIBMM, Univ. Montpellier, ENSCM, CNRS, Montpellier, France.
Laurent DevelCEA, INRAE, Médicaments et Technologies pour La Santé (MTS), SIMoS, Université Paris-Saclay, Gif-sur-Yvette, France.ORCID 0000-0002-4464-5826

Funding

French National Research Agency ANR-18-CE44-0012French National Research Agency ANR-24-CE44-0275Slovenian Research and Innovation Agency J3-4504Slovenian Research and Innovation Agency N3-0394Slovenian Research and Innovation Agency NC-0023Slovenian Research and Innovation Agency NC-25002Slovenian Research and Innovation Agency P1-0245
6 · The paper itself

Abstract

Conventional activity-based probes in activity-based protein profiling (ABPP) require enrichment or reporter tags for detection, which limits sensitivity and multiplexing. Here, we present an enrichment-free chemoproteomic approach that enables direct mass spectrometric detection by Matrix-Assisted Laser Desorption/Ionization (MALDI) of active proteases. An active-site-directed affinity probe transfers, through a proximity-induced reaction, a MALDI-detectable α-cyano-4-hydroxycinnamic acid (CHCA) tag exclusively to catalytically active forms of matrix metalloproteases (MMPs). The CHCA label enhances ionization efficiency and markedly improves signal-to-noise ratios, allowing confident identification of CHCA-labelled peptides under discriminating analytical conditions. Each active metalloprotease is thereby, associated with a distinct set of CHCA signature peptides, defining its activity fingerprint. This workflow achieves multiplexed and quantitative activity profiling of MMPs, directly in complex proteomes. This design expands ABPP into the mass spectrometry domain and establishes a robust platform for activity-based enzyme detection.

Indexed as

Matrix MetalloproteinasesCoumaric AcidsHumansPeptidesProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionizationalpha-cyano-4-hydroxycinnamateCoumaric AcidsMatrix MetalloproteinasesPeptidesactivity‐based probeschemoproteomicmass tagproximity‐induced labeling

Identifiers

PMID41934182
PMCPMC13245609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.